Hostname: page-component-76d6cb85b7-hqrjx Total loading time: 0 Render date: 2026-07-16T10:14:23.085Z Has data issue: false hasContentIssue false

Impulsivity-related predictors of adolescent substance use initiation

Published online by Cambridge University Press:  06 February 2026

Jodi Gilman*
Affiliation:
Massachusetts General Hospital , USA Department of Psychiatry, Harvard Medical School, USA
Kevin Potter
Affiliation:
Massachusetts General Hospital , USA Department of Psychiatry, Harvard Medical School, USA
Jasmeen Kaur
Affiliation:
Massachusetts General Hospital , USA
Phil Lee
Affiliation:
Massachusetts General Hospital , USA Department of Psychiatry, Harvard Medical School, USA
Randi Schuster
Affiliation:
Massachusetts General Hospital , USA Department of Psychiatry, Harvard Medical School, USA
James Bjork
Affiliation:
Virginia Commonwealth University , USA
Alexander Weigard
Affiliation:
University of Michigan Medicine School , USA
A. Eden Evins
Affiliation:
Massachusetts General Hospital , USA Department of Psychiatry, Harvard Medical School, USA
Joshua Roffman
Affiliation:
Massachusetts General Hospital , USA Department of Psychiatry, Harvard Medical School, USA
Brenden Tervo-Clemmens*
Affiliation:
University of Minnesota , USA
*
Corresponding authors: Jodi Gilman and Brenden Tervo-Clemmens; Emails: JGILMAN1@mgh.harvard.edu; btervocl@umn.edu
Corresponding authors: Jodi Gilman and Brenden Tervo-Clemmens; Emails: JGILMAN1@mgh.harvard.edu; btervocl@umn.edu
Rights & Permissions [Opens in a new window]

Abstract

Background

Neurodevelopmental models regard impulsivity as a central risk factor for adolescent substance use. However, the practical utility of impulsivity in predicting substance use is complicated by variability among measures that encompass multiple methods and theoretical domains. Prior research has been constrained by cross-sectional designs, small sample sizes, and/or the use of a narrow subset of impulsivity measures.

Method

Leveraging the ABCD dataset (n = 11,868), we identified and replicated correlations among impulsivity measures and assessed their prospective longitudinal and concurrent predictive utility regarding adolescent substance use outcomes before 15 years old. We then used simulation to inform how associations between impulsivity and substance use vary across sampling strategies (population vs. high-risk cohorts) and sample sizes.

Findings

Correlations between questionnaire and behavioral measures of impulsivity were small, and questionnaires significantly outperformed behavioral measures in predicting substance use initiation, largely due to the contribution of the CBCL externalizing scale. Predictions of substance use based on impulsivity were statistically detectable but small according to clinical standards (AUCs 0.6–0.76), exhibiting sensitivity to sample size and base rate of substance use, and thus, poor absolute predictive performance. Large samples (n > 1,000) were needed to achieve adequate power for impulsivity measures to predict substance use initiation.

Conclusion

These results support a significant but small contribution of impulsivity in predicting the onset of early adolescent substance use, indicating that these factors alone are insufficient for clinically deployable prediction. In community samples, large sample sizes are needed for reproducible impulsivity prediction of adolescent substance use.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press
Figure 0

Figure 1. Developmental patterns of substance use initiation and perceived harm. (a) The proportion of adolescents who reported initiating substance use (see Methods) at each time point for alcohol (red), nicotine/tobacco (orange), cannabis (green), and any substance (blue) is presented. Initiation – defined as more than a sip of alcohol or more than a puff of nicotine/tobacco or cannabis – was carried forward from previous years. Proportions are calculated based on non-missing cases. Error bars represent 95% uncertainty intervals (see Methods). (b) The average perceived harm of alcohol, nicotine/tobacco, and cannabis, along with the overall average of the three, at each time point is displayed. The perception of harm was evaluated on a scale of 0–3, with 3 indicating the highest level of harm. Error bars indicate 95% uncertainty intervals using the T-distribution.

Figure 1

Figure 2. Correlations among impulsivity measures at the baseline assessment. (a) Correlation heatmap using Kendall’s τ for baseline impulsivity measures. Correlations with an absolute magnitude exceeding our pre-established threshold of .08 are shown in color (positive correlations: red, negative correlations: blue). Correlations below this threshold are shown in white. (b) Absolute magnitude of correlations (1) among questionnaire (Quest.) impulsivity (Imp.) measures, (2) among behavioral measures, and (3) between behavioral (Beh.) and questionnaire measures. Abbreviations: UPPS, Urgency-Premeditation-Perseverance-Sensation Seeking-Positive Urgency; NU, Negative Urgency subscale; PR Premeditation subscale; PE, Perseverance subscale; SS, Sensation Seeking subscale, PU, Positive Urgency subscale; BAS, Behavioral Activation System; DR, Drive subscale; FS, Fun Seeking subscale; RR, Reward Responsiveness subscale of the BAS; CBCL-E; the Externalizing (E) subscale of the Child Behavioral Checklist without substance use items; DDT – ln(k), the estimate of the log of the delay discounting rate; SST – SSRT, the estimate of the stop signal reaction time of the Stop Signal Task; FT, NIH toolbox flanker task; Imp, impulsivity; Quest, questionnaire; Beh, behavioral.

Figure 2

Figure 3. Impulsivity predictors of substance use initiation. (a) Odds ratios and 95% uncertainty intervals for each baseline impulsivity measure from the full model predicting any substance use initiation by year 3 (Circles represent estimates from the model fitted to the discovery data, while triangles denote estimates from the model fitted to the validation data; filled symbols indicate estimates with FDR-adjusted p < .05; see Supplementary Tables 2.1–2.4). (b) Area under the curve with 95% uncertainty intervals for baseline models fitted to the discovery data predicting substance use initiation based on the validation data; see Supplementary Table 2.5). (c) Odds ratios and 95% uncertainty intervals for each Year 2/3 (concurrent) impulsivity measure from the full model predicting any substance use initiation by year 3; see Supplementary Tables 3.1–3.4). (d) Area under the curve with 95% uncertainty intervals for concurrent models fitted to the discovery data, predicting substance use initiation from the validation data; see Supplementary Table 3.5.

Figure 3

Figure 4. Impulsivity predictors of substance use perceived harm. (a) Change in percent total and 95% uncertainty intervals for each baseline impulsivity measure from the full model predicting total perceived harms at year 3 (Circles represent estimates from the model fitted to the discovery data, while triangles denote estimates from the model fitted to the validation data; filled symbols indicate estimates with adjusted p < .05; see Supplementary Tables 4.1–4.4). (b) Area under the curve with 95% uncertainty intervals for out-of-sample baseline predictors of perceived harm (models fitted to the discovery data predict a binary dichotomization of the total score using a median split from the validation data; see Supplementary Table 4.5). (c) Change in percent total and 95% uncertainty intervals for each Year 2/3 (concurrent) impulsivity measure from the full model predicting total perceived harms at year 3; see Supplementary Tables 5.1–5.4). (d) Area under the curve with 95% uncertainty intervals for out-of-sample concurrent predictors of perceived harm (models fitted to the discovery data, predicting a binary dichotomization of the total score using a median split from the validation data; see Supplementary Table 5.5).

Figure 4

Figure 5. Power for within-sample odds ratios and out-of-sample AUC performance. Power estimates represent the percentage of significant (p < .05) results obtained from a Monte Carlo procedure with 2,016 repetitions. Simulation data were generated through resampling with replacement from the original ABCD data. All results are derived from logistic regression models that incorporate all predictors from the full model (see Methods), using coefficients set to point estimates from the full model fit to the original discovery data (cf, Figure 3). Power under varying base rates was determined by adjusting the value of the intercept in the generating model (see Methods). (a) Power to detect a significant odds ratio for the subset of best-performing predictors within each impulsivity measure, using a multivariate logistic regression fitted to all predictors for simulated discovery data assuming a base substance use rate of approximately 3%. (b) Power to detect a significant enhancement in AUC relative to an intercept-only model when predicting simulated outcomes from the validation data based on fits to the discovery data, given a substance use base rate of approximately 3%. Power is displayed for (a) the full model with all predictors (black) and (b) for reduced models that only include the best-performing predictor within an impulsivity measure. (c) Same as (a) but with a base rate of 50%. (d) Same as (b), but with a base rate of approximately 50%.

Supplementary material: File

Gilman et al. supplementary material

Gilman et al. supplementary material
Download Gilman et al. supplementary material(File)
File 1.1 MB